Yuichiro Koide
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Addendum: Versatile phosphonium-catechol dispersant for inorganic nanoparticle stability across diverse media and manufacturing processes.
Journal: Communications chemistry
Published: April 13, 2026
Versatile phosphonium-catechol dispersant for inorganic nanoparticle stability across diverse media and manufacturing processes.
Journal: Communications chemistry
Published: June 11, 2025
Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study.
Journal: International journal of hematology
Published: March 17, 2022
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.
Journal: International journal of clinical oncology
Published: September 20, 2021
Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia.
Journal: International journal of hematology
Published: December 20, 2019
Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.
Journal: International journal of hematology
Published: February 01, 2017
Red fluorescent probe for monitoring the dynamics of cytoplasmic calcium ions.
Journal: Angewandte Chemie (International ed. in English)
Published: December 25, 2012
A reversible near-infrared fluorescence probe for reactive oxygen species based on Te-rhodamine.
Journal: Chemical communications (Cambridge, England)
Published: February 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026